ArticleFrontiers in immunology2025

Polatuzumab vedotin plus rituximab with chemotherapy in newly diagnosed pediatric stage IV Burkitt lymphoma: case report highlighting early complete remission.

Yanyan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.